Biogenesis and Function of circRNAs in Pulmonary Fibrosis

Author:

Zhang Songzi1,Hu Wenjie1,Lv Changjun12,Song Xiaodong12

Affiliation:

1. Department of Cellular and Genetic Medicine, Binzhou Medical University, Yantai, 264003, China

2. Department of Respiratory and Critical Care Medicine, Binzhou Medical University Hospital, Binzhou Medical University, Binzhou 256603, China

Abstract

Abstract: Pulmonary fibrosis is a class of fibrosing interstitial lung diseases caused by many pathogenic factors inside and outside the lung, with unknown mechanisms and without effective treatment. Therefore, a comprehensive understanding of the molecular mechanism implicated in pulmonary fibrosis pathogenesis is urgently needed to develop new and effective measures. Although circRNAs have been widely acknowledged as new contributors to the occurrence and development of diseases, only a small number of circRNAs have been functionally characterized in pulmonary fibrosis. Here, we systematically review the biogenesis and functions of circRNAs and focus on how circRNAs participate in pulmonary fibrogenesis by influencing various cell fates. Meanwhile, we analyze the current exploration of circRNAs as a diagnostic biomarker, vaccine, and therapeutic target in pulmonary fibrosis and objectively discuss the challenges of circRNA- based therapy for pulmonary fibrosis. We hope that the review of the implication of circRNAs will provide new insights into the development circRNA-based approaches to treat pulmonary fibrosis.

Funder

National Natural Science Foundation of China

Publisher

Bentham Science Publishers Ltd.

Reference133 articles.

1. Pugashetti J.V.; Adegunsoye A.; Wu Z.; Lee C.T.; Srikrishnan A.; Ghodrati S.; Vo V.; Renzoni E.A.; Wells A.U.; Garcia C.K.; Chua F.; Newton C.A.; Molyneaux P.L.; Oldham J.M.; Validation of proposed criteria for progressive pulmonary fibrosis. Am J Respir Crit Care Med 2023,207(1),69-76

2. Ishida Y.; Kuninaka Y.; Mukaida N.; Kondo T.; Immune mechanisms of pulmonary fibrosis with bleomycin. Int J Mol Sci 2023,24(4),3149

3. Podolanczuk A.J.; Thomson C.C.; Remy-Jardin M.; Richeldi L.; Martinez F.J.; Kolb M.; Raghu G.; Idiopathic pulmonary fibrosis: State of the art for 2023. Eur Respir J 2023,61(4),2200957

4. Raghu G.; Remy-Jardin M.; Richeldi L.; Thomson C.C.; Inoue Y.; Johkoh T.; Kreuter M.; Lynch D.A.; Maher T.M.; Martinez F.J.; Molina-Molina M.; Myers J.L.; Nicholson A.G.; Ryerson C.J.; Strek M.E.; Troy L.K.; Wijsenbeek M.; Mammen M.J.; Hossain T.; Bissell B.D.; Herman D.D.; Hon S.M.; Kheir F.; Khor Y.H.; Macrea M.; Antoniou K.M.; Bouros D.; Buendia-Roldan I.; Caro F.; Crestani B.; Ho L.; Morisset J.; Olson A.L.; Podolanczuk A.; Poletti V.; Selman M.; Ewing T.; Jones S.; Knight S.L.; Ghazipura M.; Wilson K.C.; Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: An official ats/ers/jrs/alat clinical practice guideline. Am J Respir Crit Care Med 2022,205(9),e18-e47

5. Raghu G.; Remy-Jardin M.; Myers J.L.; Richeldi L.; Ryerson C.J.; Lederer D.J.; Behr J.; Cottin V.; Danoff S.K.; Morell F.; Flaherty K.R.; Wells A.; Martinez F.J.; Azuma A.; Bice T.J.; Bouros D.; Brown K.K.; Collard H.R.; Duggal A.; Galvin L.; Inoue Y.; Jenkins R.G.; Johkoh T.; Kazerooni E.A.; Kitaichi M.; Knight S.L.; Mansour G.; Nicholson A.G.; Pipavath S.N.J.; Buendía-Roldán I.; Selman M.; Travis W.D.; Walsh S.L.F.; Wilson K.C.; Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med 2018,198(5),e44-e68

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3